SCHEMBL3847026

SCHEMBL3847026

CSc1ccc(-c2nn(C(c3ccccc3)(c3ccccc3)c3ccccc3)cc2-c2ccc3ncnc(-c4ccc(S(C)(=O)=O)s4)c3c2)cc1

nearest known ligand 0.32

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
STK17B O94768 1/20 0.32
MAP3K8 P41279 1/20 0.32
STK17A Q9UEE5 1/20 0.32
CA12 O43570 1/20 0.31
CA1 P00915 1/20 0.31
CA2 P00918 1/20 0.31
CA9 Q16790 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3846261 0.91 CA12 (0.34) CA12CA1CA2CA9
SCHEMBL3853047 0.91 CA12 (0.32) CA12CA1CA2CA9
SCHEMBL3854489 0.91 PTGS2 (0.35) CA12CA1CA2CA9
SCHEMBL3854275 0.90 CYP3A4 (0.33) STK17BCA12CA1CA2CA9
SCHEMBL3851760 0.89 MAP4K4 (0.33) MAP3K8CA12CA1CA2CA9
SCHEMBL3845263 0.89 CYP1A2 (0.34) CA12CA1CA2CA9
SCHEMBL3849245 0.88 MAP4K4 (0.33) STK17BMAP3K8CA12CA1CA2
SCHEMBL3855222 0.87 CYP1A2 (0.34)
SCHEMBL3849354 0.87 SCN9A (0.34) STK17B
SCHEMBL4714668 0.87 AURKA (0.35) CA12CA1CA2CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2048142-A2 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof Eisai R&D Management Co., Ltd. (JP) 2009-04-15 EP disclosed
EP-1382603-B1 NITROGENOUS FUSED-RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF EISAI R&D MAN CO LTD (JP) 2008-07-23 EP disclosed
US-7074801-B1 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof EISAI CO., LTD. (JP) 2006-07-11 US disclosed
EP-1382603-A1 NITROGENOUS FUSED−RING COMPOUND HAVING PYRAZOLYL GROUP AS SUBSTITUENT AND MEDICINAL COMPOSITION THEREOF Eisai Co., Ltd. (JP) 2004-01-21 EP disclosed